Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Modified Fluorene Compound Potently Disrupts Amyloid-β
Fluorene modified with pyrroline nitroxide has antioxidant properties, disrupts Aβ oligomers

This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

May 23, 2013

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Stroke-Related Costs Expected to Rise 129 Percent by 2030

Systematic Screening of Med Adherence Will ID Barriers

ATS: Lung Cancer Diagnosis 7 Percent With Low-Dose CT

ATS: Genetic Variant Tied to Interstitial Lung Disease

Stimulant Normalizes Brain Activation in Youth With ADHD

ATS: Azithromycin Delays Next Hospitalization in COPD
HealthDay Corporate Web Site

Legal Statement | Copyright © 2013 HealthDay. All rights reserved.

This site complies with the HONcode standard for trustworthy health information: verify here.
This website is certified by Health On the Net Foundation. Click to verify.